Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1093
http://purl.obolibrary.org/obo/NCIT_C1093
|
|---|---|
| Preferred Name | Etoposide Phosphate |
| Definitions |
A phosphate salt of a semisynthetic derivative of podophyllotoxin. Etoposide binds to the enzyme topoisomerase II, inducing double-strand DNA breaks, inhibiting DNA repair, and resulting in decreased DNA synthesis and tumor cell proliferation. Cells in the S and G2 phases of the cell cycle are most sensitive to this agent. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A phosphate salt of a semisynthetic derivative of podophyllotoxin. Etoposide binds to the enzyme topoisomerase II, inducing double-strand DNA breaks, inhibiting DNA repair, and resulting in decreased DNA synthesis and tumor cell proliferation. Cells in the S and G2 phases of the cell cycle are most sensitive to this agent. (NCI04) |
|---|---|
| prefLabel | Etoposide Phosphate
|
| label | Etoposide Phosphate
|
| PDQ_Closed_Trial_Search_ID | 42801
|
| code | C1093
|
| Has_Target | |
| prefixIRI | NCIT:C1093
|
| in_subset |
See more
See less
|
| Display_Name | Etoposide Phosphate
|
| Preferred_Name | Etoposide Phosphate
|
| FDA_UNII_Code | 528XYJ8L1N
|
| Contributing_Source |
CTRP
FDA
PCDC
|
| Chemical_Formula | C29H33O16P
|
| Maps_To | Etoposide Phosphate
|
| CAS_Registry | 117091-64-2
|
| NCI_Drug_Dictionary_ID | 42801
|
| Legacy Concept Name | Etoposide_Phosphate
|
| Is_PCDC_GCT_Permissible_Value_For_Variable | |
| type | |
| ALT_DEFINITION | A drug used to treat testicular and small cell lung cancers. It is also being studied in the treatment of several other types of cancer. Etopophos blocks certain enzymes needed for cell division and DNA repair, and it may kill cancer cells. It is a type of podophyllotoxin derivative and a type of topoisomerase inhibitor.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42801
|
| Accepted_Therapeutic_Use_For | Langerhans cell histiocytosis; Mobilization of peripheral-blood progenitor cells; Multiple myeloma; Neuroblastoma; Non-small lung cancer; Osteogenic sarcoma; Ovarian cancer; Retinoblastoma; Small cell lung cancer; Soft tissue sarcomas
Hepatocellular cancer; Hodgkins disease; Hypereosinophilic syndrome; Kaposis sarcoma; Testicular cancer; Thymoma; Thyroid cancer; Uterine cancer; Wilms tumor
Acute leukemia; Adrenal cortical cancer; Brain cancer; Chronic lymphocytic leukemia; Choriocarcinoma; Esophageal cancer; Ewings sarcoma; Gastric cancer; Germ cell cancer; Gestational trophoblastic neoplasms
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0059874
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |